Nuveen’s Biodesix BDSX Stock Holding History

Nuveen’s Portfolio BDSX Stock Details BDSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-976	Closed	-$39K	–	3259
2022 Q1	$39K	Hold	976	–	–	﹤0.01%	3283
2021 Q4	$89K	Sell	976 -512	-34%	-$66.9K	﹤0.01%	3287
2021 Q3	$259K	Buy	1,488 +512	+52%	+$97.1K	﹤0.01%	3267
2021 Q2	$258K	Buy	+976	New	+$307K	﹤0.01%	3231

Other funds holding BDSX

Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

ECM

Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Nuveen's BDSX Position: Q2 2022 in Review

Nuveen sold out of Biodesix (BDSX) in Q2 2022, closing a stake of 976 shares — an estimated $39K sold.

Nuveen first reported a position in BDSX in Q2 2021 and held it in 4 quarters. The position peaked at $259K in Q3 2021. 36 funds tracked by Wall St. Rank hold BDSX as of Q2 2022.

Nuveen reported no remaining Biodesix position as of Q2 2022 after selling out during the quarter.
Nuveen sold 976 Biodesix shares in Q2 2022, an estimated $39K.
Nuveen first reported a position in Biodesix in Q2 2021 and held it in 4 quarters.
Nuveen's Biodesix position peaked at $259K in Q3 2021.
36 funds tracked by Wall St. Rank held Biodesix as of Q2 2022.

Based on Nuveen's 13F filing for Q2 2022, filed 15 Aug 2022.